ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,148Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 783

$664K Total Retail Price of All Prescriptions

Rank: 155 out of 783

558 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,350 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 470 444 1 3
LEVOTHYROXINE SODIUM 446 424 2 1
FUROSEMIDE 446 429 2 7
AMLODIPINE BESYLATE 384 379 4 5
LISINOPRIL 277 247 5 4
HYDROCHLOROTHIAZIDE 211 195 6 12
HYDROCODONE-ACETAMINOPHEN 204 149 S3 7 2
METOPROLOL SUCCINATE 193 174 8 13
ATENOLOL 186 165 9 17
CITALOPRAM HBR 186 179 9 19
DONEPEZIL HCL 167 167 11 24
LOSARTAN-HYDROCHLOROTHIAZIDE 165 152 12 53
ATORVASTATIN CALCIUM 157 154 13 11
TRAMADOL HCL 152 136 14 20
OMEPRAZOLE 149 140 15 6
METFORMIN HCL 147 133 16 8
PRAVASTATIN SODIUM 146 137 17 14
WARFARIN SODIUM 139 139 18 10
ZOLPIDEM TARTRATE 137 124 19 23
GLIPIZIDE 136 117 20 71
LOSARTAN POTASSIUM 132 116 21 18
AZITHROMYCIN 121 107 22 41
METOPROLOL TARTRATE 120 118 23 9
FLUTICASONE PROPIONATE 115 97 24 46
CLOPIDOGREL 114 114 25 29
GABAPENTIN 107 106 26 15
TRIAMTERENE-HCTZ 106 106 27 42
LANTUS 106 92 27 38
TAMSULOSIN HCL 105 95 29 26
POTASSIUM CHLORIDE 103 96 30 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 101 31 33
MELOXICAM 100 82 32 37
PLAVIX 95 95 33 51
NAMENDA 91 91 34 32
DIOVAN 82 82 35 49
SINGULAIR 82 81 35 90
CARVEDILOL 81 70 37 21
FENOFIBRATE 76 58 38 66
ALLOPURINOL 75 75 39 31
LANTUS SOLOSTAR 73 73 40 91
NEXIUM 72 63 41 28
MIRTAZAPINE 70 70 42 52
TRAZODONE HCL 69 57 43 39
PANTOPRAZOLE SODIUM 66 66 44 30
CELEBREX 65 65 45 93
ALENDRONATE SODIUM 64 63 46 25
SYNTHROID 62 61 47 47
ENALAPRIL MALEATE 58 58 48 68
ADVAIR DISKUS 57 56 49 50
CLONIDINE HCL 55 55 50 60
PREDNISONE 55 55 50 36
VERAPAMIL ER 54 54 52 119
SERTRALINE HCL 54 47 52 22
CYMBALTA 54 30 52 35
OXYBUTYNIN CHLORIDE 53 50 55 96
SPIRONOLACTONE 53 53 55 57
ESCITALOPRAM OXALATE 53 53 55 54
CYCLOBENZAPRINE HCL 52 47 R 58 63
HUMALOG 52 47 58 101
GLIPIZIDE ER 50 50 60 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.